National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting, 42530 [2013-16943]
Download as PDF
<![CDATA[
42530
Federal Register / Vol. 78, No. 136 / Tuesday, July 16, 2013 / Notices
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel Review of the Diversity
Program
Date: July 23, 2013.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Raul A. Saavedra, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–496–9223,
saavedrr@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel P30 and R24 Review.
Date: August 7, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Chicago—O’Hare/
Rosemont, 550 North River Road, Rosemont,
IL 60018.
Contact Person: William C. Benzing, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–496–0660,
benzingw@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel Stroke Trials Network NCCC
SEP.
Date: August 15, 2013.
Time: 8:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–435–6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel Stroke Trial Network Sites.
Date: August 15–16, 2013.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–435–6033, rajarams@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: July 10, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–16945 Filed 7–15–13; 8:45 am]
emcdonald on DSK67QTVN1PROD with NOTICES
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
18:49 Jul 15, 2013
Jkt 229001
Dated: July 10, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–16943 Filed 7–15–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of an Exclusive
License: Human Papillomavirus 16 E2
and E6 Peptides for Cervical Cancer
Vaccine Development
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This is notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the National Institutes of Health
(NIH), Department of Health and Human
Services, is contemplating the grant of
an exclusive worldwide license to
practice the inventions embodied in:
SUMMARY:
Patent application
No.
E–126–2001/0–AU–06 ................................................................
E–126–2001/0–CA–04 ................................................................
E–126–2001/0–EP–05 .................................................................
E–126–2001/0–PCT–02 ..............................................................
E–126–2001/0–US–01 ................................................................
E–126–2001/0–US–03 ................................................................
E–126–2001/0–US–07 ................................................................
E–155–2005/0–US–01 ................................................................
E–155–2005/1–US–01 ................................................................
E–155–2005/2–US–01 ................................................................
E–155–2005/3–AU–04 ................................................................
VerDate Mar<15>2010
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Clinical, Treatment and
Health Services Research Review
Subcommittee.
Date: October 15, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIAAA, 5635 Fishers Lane, T508 Rockville,
MD 20852.
Contact Person: Katrina L Foster, Ph.D.,
Scientific Review Officer, National Institute
on Alcohol Abuse & Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Rm.
2019, Rockville, MD 20852, 301–443–4032,
katrina@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.273, Alcohol Research
Programs; National Institutes of Health, HHS)
BILLING CODE 4140–01–P
NIH Ref. No.
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00045
Fmt 4703
Filing date
Issued patent no.
(if any)
2002258614
2441947
2728570.9
PCT/US02/09261
60/278,520
10/472,661
11/685,632
60/671,463
60/680,000
60/724,783
2006236905
March 22, 2002 ..................
March 22, 2002 ..................
March 22, 2002 ..................
March 22, 2002 ..................
March 23, 2001 ..................
September 23, 2003 ..........
March 13, 2007 ..................
April 15, 2005 .....................
May 12, 2005 .....................
October 11, 2005 ...............
April 11, 2006 .....................
2002258614
..............................
..............................
(Expired)
(Expired)
7,189,513
7,507,538
(Expired)
(Expired)
(Expired)
..............................
Sfmt 4703
E:\FR\FM\16JYN1.SGM
16JYN1
]]>Agencies
[Federal Register Volume 78, Number 136 (Tuesday, July 16, 2013)]
[Notices]
[Page 42530]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16943]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Initial Review Group; Clinical, Treatment and Health
Services Research Review Subcommittee.
Date: October 15, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, NIAAA, 5635 Fishers Lane,
T508 Rockville, MD 20852.
Contact Person: Katrina L Foster, Ph.D., Scientific Review
Officer, National Institute on Alcohol Abuse & Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Rm. 2019, Rockville, MD
20852, 301-443-4032, katrina@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program No. 93.273,
Alcohol Research Programs; National Institutes of Health, HHS)
Dated: July 10, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-16943 Filed 7-15-13; 8:45 am]
BILLING CODE 4140-01-P
